Cargando…

Mass Spectrometry as a Highly Sensitive Method for Specific Circulating Tumor DNA Analysis in NSCLC: A Comparison Study

SIMPLE SUMMARY: We compared the UltraSEEK™ Lung Panel on the MassARRAY(®) System (Agena Bioscience) with the FDA-approved Cobas(®) EGFR Mutation Test v2 for the detection of EGFR mutations in liquid biopsies of NSCLC patients, accompanied with preanalytical sample assessment using the novel Liquid I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lamy, Pierre-Jean, van der Leest, Paul, Lozano, Nicolas, Becht, Catherine, Duboeuf, Frédérique, Groen, Harry J. M., Hilgers, Werner, Pourel, Nicolas, Rifaela, Naomi, Schuuring, Ed, Alix-Panabières, Catherine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602843/ https://www.ncbi.nlm.nih.gov/pubmed/33081150 http://dx.doi.org/10.3390/cancers12103002

Ejemplares similares

Detection and Monitoring of Tumor-Derived Mutations in Circulating Tumor DNA Using the UltraSEEK Lung Panel on the MassARRAY System in Metastatic Non-Small Cell Lung Cancer Patients
por: van der Leest, Paul, et al.
Publicado: (2023)

Circulating tumor DNA as a biomarker for monitoring early treatment responses of patients with advanced lung adenocarcinoma receiving immune checkpoint inhibitors
por: van der Leest, Paul, et al.
Publicado: (2021)

The potential of combined mutation sequencing of plasma circulating cell‐free DNA and matched white blood cells for treatment response prediction
por: van der Leest, Paul, et al.
Publicado: (2020)

“Circulating Tumor Cells: Finding Rare Events for a Huge Knowledge of Cancer Dissemination”
por: Alix-Panabières, Catherine
Publicado: (2020)

Cell lines from circulating tumor cells
por: Pantel, Klaus, et al.
Publicado: (2015)

Mechanobiology and survival strategies of circulating tumor cells: a process towards the invasive and metastatic phenotype
por: Kurma, Keerthi, et al.
Publicado: (2023)

Crucial roles of circulating tumor cells in the metastatic cascade and tumor immune escape: biology and clinical translation
por: Pantel, Klaus, et al.
Publicado: (2022)

Clinical relevance and biology of circulating tumor cells
por: Bednarz-Knoll, Natalia, et al.
Publicado: (2011)

Dissemination of circulating tumor cells at night: role of sleep or circadian rhythm?
por: Dauvilliers, Yves, et al.
Publicado: (2022)

Never Travel Alone: The Crosstalk of Circulating Tumor Cells and the Blood Microenvironment
por: Heeke, Simon, et al.
Publicado: (2019)

Epithelial Cell Adhesion Molecule: An Anchor to Isolate Clinically Relevant Circulating Tumor Cells
por: Eslami-S, Zahra, et al.
Publicado: (2020)

Comparison of Circulating Cell-Free DNA Extraction Methods for Downstream Analysis in Cancer Patients
por: van der Leest, Paul, et al.
Publicado: (2020)

Autologous cell lines from circulating colon cancer cells captured from sequential liquid biopsies as model to study therapy-driven tumor changes
por: Soler, Alexandra, et al.
Publicado: (2018)

Current Applications and Discoveries Related to the Membrane Components of Circulating Tumor Cells and Extracellular Vesicles
por: Cortés-Hernández, Luis Enrique, et al.
Publicado: (2021)

Circulating Tumor Cell Detection and Polyomavirus Status in Merkel Cell Carcinoma
por: Boyer, Magali, et al.
Publicado: (2020)

Functional analysis of circulating tumour cells: the KEY to understand the biology of the metastatic cascade
por: Eslami-S, Zahra, et al.
Publicado: (2022)

Selective treatment pressure in colon cancer drives the molecular profile of resistant circulating tumor cell clones
por: Cayrefourcq, Laure, et al.
Publicado: (2021)

Epithelial-to-Mesenchymal Plasticity in Circulating Tumor Cell Lines Sequentially Derived from a Patient with Colorectal Cancer
por: Balcik-Ercin, Pelin, et al.
Publicado: (2021)

Liquid biopsy: from discovery to clinical implementation
por: Alix‐Panabières, Catherine, et al.
Publicado: (2021)

Circulating Tumor Cell Detection by Liquid Biopsy during Early-Stage Endometrial Cancer Surgery: A Pilot Study
por: Francini, Sarah, et al.
Publicado: (2023)

Circulating tumor cells in advanced non-small cell lung cancer patients are associated with worse tumor response to checkpoint inhibitors
por: Tamminga, Menno, et al.
Publicado: (2019)

The Role of Circulating Tumor Cells in the Metastatic Cascade: Biology, Technical Challenges, and Clinical Relevance
por: Dianat-Moghadam, Hassan, et al.
Publicado: (2020)

Epigenomic analysis reveals a unique DNA methylation program of metastasis-competent circulating tumor cells in colorectal cancer
por: Bao-Caamano, Aida, et al.
Publicado: (2023)

Publisher Correction: Epigenomic analysis reveals a unique DNA methylation program of metastasis-competent circulating tumor cells in colorectal cancer
por: Bao-Caamano, Aida, et al.
Publicado: (2023)

High Sensitivity of Circulating Tumor Cells Derived from a Colorectal Cancer Patient for Dual Inhibition with AKT and mTOR Inhibitors
por: Smit, Daniel J., et al.
Publicado: (2020)

Stereotactic radiotherapy for brain metastases: predictive factors of radionecrosis
por: Calderon, Benoît, et al.
Publicado: (2023)

Microsieves for the detection of circulating tumor cells in leukapheresis product in non-small cell lung cancer patients
por: Tamminga, Menno, et al.
Publicado: (2020)

A Nationwide Study on the Impact of Routine Testing for EGFR Mutations in Advanced NSCLC Reveals Distinct Survival Patterns Based on EGFR Mutation Subclasses
por: Koopman, Bart, et al.
Publicado: (2021)

Micrometastatic spread in breast cancer: detection, molecular characterization and clinical relevance
por: Fehm, Tanja, et al.
Publicado: (2008)

The Metastatic Cascade as the Basis for Liquid Biopsy Development
por: Eslami-S, Zahra, et al.
Publicado: (2020)

Functional Analysis of Viable Circulating Tumor Cells from Triple-Negative Breast Cancer Patients Using TetherChip Technology
por: Vardas, Vasileios, et al.
Publicado: (2023)

S100-EPISPOT: A New Tool to Detect Viable Circulating Melanoma Cells
por: Cayrefourcq, Laure, et al.
Publicado: (2019)

Immune microenvironment composition in non‐small cell lung cancer and its association with survival
por: Tamminga, Menno, et al.
Publicado: (2020)

Tumor‐proximal liquid biopsy to improve diagnostic and prognostic performances of circulating tumor cells
por: Buscail, Etienne, et al.
Publicado: (2019)

Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials
por: Bidard, François-Clément, et al.
Publicado: (2012)

Clinical Relevance of Liquid Biopsy in Melanoma and Merkel Cell Carcinoma
por: Boyer, Magali, et al.
Publicado: (2020)

Liquid Biopsy in Melanoma: Significance in Diagnostics, Prediction and Treatment Monitoring
por: Kamińska, Paula, et al.
Publicado: (2021)

Detection of Circulating Tumor Cells in the Diagnostic Leukapheresis Product of Non-Small-Cell Lung Cancer Patients Comparing CellSearch(®) and ISET
por: Tamminga, Menno, et al.
Publicado: (2020)

Circulating Tumor Cells as a Marker of Disseminated Disease in Patients with Newly Diagnosed High-Risk Prostate Cancer
por: Cieślikowski, Wojciech A., et al.
Publicado: (2020)

Analysis of Circulating Tumor Cells in Patients with Non-Metastatic High-Risk Prostate Cancer before and after Radiotherapy Using Three Different Enumeration Assays
por: Budna-Tukan, Joanna, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1g3lqc2758n1cjmsn2jqudkuq9